A 9-year retrospective assessment of laboratory testing for activated protein C resistance: Evolution of a novel approach to thrombophilia investigations

Pathology

Volumn 34, Issue 4, 2002, Pages 348-355

  Favaloro, Emmanuel J ^a   Orsag, Ina ^a   Bukuya, Melinda ^a   McDonald, David ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Activated protein C resistance; APCR; APTT; Diagnosis; Factor V Leiden; Laboratory assessment; RVVT; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; DNA; ACTIVATED PROTEIN C;

ACTIVATED PROTEIN C RESISTANCE; ARTICLE; EVALUATION; GENETICS; HUMAN; MEDICAL TECHNOLOGY; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RETROSPECTIVE STUDY; STANDARD; THROMBOPHILIA; ALGORITHM; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DNA DETERMINATION; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; LABORATORY TEST; MAJOR CLINICAL STUDY;

ACTIVATED PROTEIN C RESISTANCE; DNA; FACTOR V; HUMANS; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RETROSPECTIVE STUDIES; TECHNOLOGY, MEDICAL; THROMBOPHILIA;

EID: 0036020467     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/003130202760120526     Document Type: Article

References (41)

1. Familial Thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C
2. Anticoagulant protein C pathway defective in majority of thrombophilic patients
3. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study
4. Resistance to activated protein C as a basis for venous thrombosis
5. Frequency of a defective response to activated protein C in patients with a history of venous thrombosis
6. Mutation in blood coagulation factor V associated with resistance to activated protein C
7. Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V
8. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis
9. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C
10. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
11. Use of first nucleotide change technology to determine the frequency of factor V Leiden in a population of Australian blood donors
12. Detection of a common mutation in factor V gene responsible for resistance to activate protein C causing predisposition to thrombosis
13. Prevalence of activated protein C resistance and analysis of clinical profile in thromboembolic patients. A Belgian prospective study
14. Sensitivity and specificity of the APC resistance assay in detection of individuals with factor V Leiden
15. Factor V R506Q gene mutation analysis by PCR-RFLP: Optimization, comparison with functional testing for resistance to activated protein C, and establishment of cell line controls
16. Detection of the factor V Leiden mutation: Development of a testing algorithm combining a coagulation assay and molecular diagnosis
17. Functional activated protein C resistance assays: Correlation with factor V DNA analysis is better with RVVT- than APTT-based assays
18. Resistance to activated protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons
19. Modified test for activated protein C resistance
20. Modified APC resistance assay for patients on oral anticoagulants
21. Diagnosis of APC resistance in patients on oral anticoagulant therapy
22. Evaluation of APC resistance in the plasma of patients with Q506 mutation of factor V (factor V Leiden) and treated by oral anticoagulants
23. Improved characteristics of aPC-R assay: Coatest aPC resistance by predilution of samples with factor V deficient plasma
24. Laboratory diagnosis of APC-resistance: A critical evaluation of the test and the development of diagnostic criteria
25. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis
26. Screening for the FV:Q506 mutation-Evaluation of thirteen plasma based methods for their diagnostic efficacy in comparison with DNA analysis
27. A comparison between two activated protein C resistance methods as routine diagnostic tests for factor V Leiden mutation
28. SSCP analysis of PCR products to type the factor V gene
29. Utilization of testing for activated protein C resistance in a reference laboratory
30. Activated protein C resistance (APC) and inherited factor V (FV) missense mutation in patients with venous and arterial thrombosis in a haematology clinic
31. Editorial: Economy class syndrome. A misnomer for a syndrome for which the evidence is, as yet, missing
32. Detecting APC-resistant factor V: A functional method without plasma dilution
33. The factor V (Leiden) test: Evaluation of an assay based on dilute Russell Viper Venom Time for the detection of the factor V Leiden mutation
34. Factor V Cambridge: A new mutation (Arg306 > Thr) associated with resistance to activated protein C
35. A novel mutation of Arg 306 of factor V in Hong Kong Chinese
36. The factor V gene A4070G mutation and the risk of venous thrombosis
37. Genetic approach to thrombophilia
38. The influence of factor VIII on measurement of activated protein C resistance
39. The impact of anticoagulant therapy, factor VIII level and quality of factor V-deficient plasma on three commercial methods for activated protein C resistance